FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2105526885> ?p ?o ?g. }

• W2105526885 endingPage "1500" @default.
• W2105526885 startingPage "1481" @default.
• W2105526885 abstract "Cellular CCAAT/enhancer binding protein alpha (C/EBPalpha) promotes cellular differentiation and has antimitotic activities involving cell cycle arrest at G(1)/S through stabilization of p21(CIP-1)/WAF1 and through transcriptional activation of the p21 promoter. The Epstein-Barr virus lytic-cycle transactivator protein ZTA is known to arrest the host cell cycle at G(1)/S via a p53-independent p21 pathway, but the detailed molecular mechanisms involved have not been defined. To further evaluate the role of ZTA in cell cycle arrest, we constructed a recombinant adenovirus vector expressing ZTA (Ad-ZTA), whose level of expression at a low multiplicity of infection in normal human diploid fibroblast (HF) cells was lower than or equal to the physiological level seen in Akata cells lytically induced by EBV (EBV-Akata cells). Fluorescence-activated cell sorting analysis of HF cells infected with Ad-ZTA confirmed that G(1)/S cell cycle arrest occurred in the majority of ZTA-positive cells, but not with an adenovirus vector expressing green fluorescent protein. Double-label immunofluorescence assays (IFA) performed with Ad-ZTA-infected HF cells revealed that only ZTA-positive cells induced the expression of both endogenous C/EBPalpha and p21 and blocked the progression into S phase, as detected by a lack of incorporation of bromodeoxyuridine. The stimulation of endogenous ZTA protein expression either through treatment with tetradecanoyl phorbol acetate in D98/HR1 cells or through B-cell receptor cross-linking with anti-immunoglobulin G antibody in EBV-Akata cells also coincided with the induction of both C/EBPalpha and p21 and their mRNAs, as assayed by Northern blot, Western blot, and IFA experiments. Mechanistically, the ZTA protein proved to directly interact with C/EBPalpha by coimmunoprecipitation in EBV-Akata cells and with DNA-bound C/EBPalpha in electrophoretic mobility shift assay experiments, and the in vitro interaction domain encompassed the basic leucine zipper domain of ZTA. ZTA also specifically protected C/EBPalpha from degradation in a protein stability assay with a non-EBV-induced Akata cell proteasome extract. Furthermore, both C/EBPalpha and ZTA were found to specifically associate with the C/EBPalpha promoter in chromatin immunoprecipitation assays, but the interaction with ZTA appeared to be mediated by C/EBPalpha because it was abolished by clearing with anti-C/EBPalpha antibody. ZTA did not bind to or activate the C/EBPalpha promoter directly but cooperatively enhanced the positive autoregulation of the C/EBPalpha promoter by cotransfected C/EBPalpha in transient luciferase reporter gene assays with Vero and HeLa cells as well as with DG75 B lymphocytes. Similarly, ZTA alone had little effect on the p21 promoter in transient reporter gene assays, but in the presence of cotransfected C/EBPalpha, ZTA enhanced the level of C/EBPalpha activation. This effect proved to require a previously unrecognized region in the proximal p21 promoter that contains three high-affinity C/EBPalpha binding sites. Finally, in C/EBPalpha-deficient mouse embryonic fibroblasts (MEF), Ad-ZTA was unable to induce either p21 or G(1) arrest, whereas it was able to induce both in wild-type MEF. Overall, we conclude that C/EBPalpha is essential for at least one pathway of ZTA-induced G(1) arrest during EBV lytic-cycle DNA replication and that this process involves a physical piggyback interaction between ZTA and C/EBPalpha leading to greatly enhanced C/EBPalpha and p21 levels through both transcriptional and posttranslational mechanisms." @default.
• W2105526885 created "2016-06-24" @default.
• W2105526885 creator A5016438289 @default.
• W2105526885 creator A5022238193 @default.
• W2105526885 creator A5026986847 @default.
• W2105526885 creator A5033103064 @default.
• W2105526885 creator A5033758256 @default.
• W2105526885 creator A5048052831 @default.
• W2105526885 creator A5055950562 @default.
• W2105526885 creator A5058575953 @default.
• W2105526885 creator A5061164194 @default.
• W2105526885 creator A5061455307 @default.
• W2105526885 date "2003-01-15" @default.
• W2105526885 modified "2023-10-14" @default.
• W2105526885 title "CCAAT/Enhancer Binding Protein α Interacts with ZTA and Mediates ZTA-Induced p21 ^CIP-1 Accumulation and G ₁ Cell Cycle Arrest during the Epstein-Barr Virus Lytic Cycle" @default.
• W2105526885 cites W1540516857 @default.
• W2105526885 cites W1555996845 @default.
• W2105526885 cites W1823218897 @default.
• W2105526885 cites W1882424684 @default.
• W2105526885 cites W1885323688 @default.
• W2105526885 cites W1966986019 @default.
• W2105526885 cites W1968191203 @default.
• W2105526885 cites W1968953063 @default.
• W2105526885 cites W1977701495 @default.
• W2105526885 cites W1987091135 @default.
• W2105526885 cites W1987598864 @default.
• W2105526885 cites W1989278316 @default.
• W2105526885 cites W1989481014 @default.
• W2105526885 cites W2005393972 @default.
• W2105526885 cites W2005902803 @default.
• W2105526885 cites W2012585409 @default.
• W2105526885 cites W2015519364 @default.
• W2105526885 cites W2019540980 @default.
• W2105526885 cites W2020649739 @default.
• W2105526885 cites W2029101025 @default.
• W2105526885 cites W2049629344 @default.
• W2105526885 cites W2062434608 @default.
• W2105526885 cites W2070121438 @default.
• W2105526885 cites W2078797418 @default.
• W2105526885 cites W2094144752 @default.
• W2105526885 cites W2095570251 @default.
• W2105526885 cites W2097411118 @default.
• W2105526885 cites W2099955175 @default.
• W2105526885 cites W2100056890 @default.
• W2105526885 cites W2107088342 @default.
• W2105526885 cites W2118578616 @default.
• W2105526885 cites W2119535180 @default.
• W2105526885 cites W2119734571 @default.
• W2105526885 cites W2121749875 @default.
• W2105526885 cites W2123711411 @default.
• W2105526885 cites W2128321553 @default.
• W2105526885 cites W2132362370 @default.
• W2105526885 cites W2135735391 @default.
• W2105526885 cites W2137105120 @default.
• W2105526885 cites W2138441377 @default.
• W2105526885 cites W2143197026 @default.
• W2105526885 cites W2143665924 @default.
• W2105526885 cites W2144714494 @default.
• W2105526885 cites W2149655243 @default.
• W2105526885 cites W2150777358 @default.
• W2105526885 cites W2158289858 @default.
• W2105526885 cites W2160142678 @default.
• W2105526885 cites W2161820428 @default.
• W2105526885 cites W2162481722 @default.
• W2105526885 cites W2162564085 @default.
• W2105526885 cites W2164112459 @default.
• W2105526885 cites W2164313428 @default.
• W2105526885 cites W2166025376 @default.
• W2105526885 cites W2209450952 @default.
• W2105526885 cites W2298027515 @default.
• W2105526885 cites W2409620969 @default.
• W2105526885 cites W2409933607 @default.
• W2105526885 cites W2620449613 @default.
• W2105526885 cites W4254079287 @default.
• W2105526885 cites W4296404860 @default.
• W2105526885 cites W94108470 @default.
• W2105526885 doi "https://doi.org/10.1128/jvi.77.2.1481-1500.2003" @default.
• W2105526885 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/140856" @default.
• W2105526885 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12502863" @default.
• W2105526885 hasPublicationYear "2003" @default.
• W2105526885 type Work @default.
• W2105526885 sameAs 2105526885 @default.
• W2105526885 citedByCount "71" @default.
• W2105526885 countsByYear W21055268852012 @default.
• W2105526885 countsByYear W21055268852013 @default.
• W2105526885 countsByYear W21055268852016 @default.
• W2105526885 countsByYear W21055268852017 @default.
• W2105526885 countsByYear W21055268852020 @default.
• W2105526885 countsByYear W21055268852022 @default.
• W2105526885 crossrefType "journal-article" @default.
• W2105526885 hasAuthorship W2105526885A5016438289 @default.
• W2105526885 hasAuthorship W2105526885A5022238193 @default.
• W2105526885 hasAuthorship W2105526885A5026986847 @default.
• W2105526885 hasAuthorship W2105526885A5033103064 @default.
• W2105526885 hasAuthorship W2105526885A5033758256 @default.
• W2105526885 hasAuthorship W2105526885A5048052831 @default.
• W2105526885 hasAuthorship W2105526885A5055950562 @default.
• W2105526885 hasAuthorship W2105526885A5058575953 @default.

• next